| Ms Gwendolyn Anne Sturges, PT | |
|
211 Water St, Elizabethtown, NY 12932-0172 | |
| (518) 873-2059 | |
| (518) 873-5814 |
| Full Name | Ms Gwendolyn Anne Sturges |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 211 Water St, Elizabethtown, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902982374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 009720 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Gwendolyn Anne Sturges, PT Po Box 172, Elizabethtown, NY 12932-0172 Ph: (518) 873-2059 | Ms Gwendolyn Anne Sturges, PT 211 Water St, Elizabethtown, NY 12932-0172 Ph: (518) 873-2059 |
News Archive
The Kansas Health Institute News offers a series of stories about caring for the health needs of state prisoners.
Chemists at The Scripps Research Institute (TSRI) have found an easier way to perform one of the most fundamental tasks in molecular biology. Their new method allows scientists to add a marker to certain cells, so that these cells may be easily located and/or selected out from a larger cell population.
A new study reveals that individuals with traumatic brain injury (TBI) have significantly more difficulty with gist reasoning than traditional cognitive tests. Using a unique cognitive assessment developed by researchers at the Center for BrainHealth at The University of Texas at Dallas, findings published Friday in the Journal of Clinical and Experimental Neuropsychology indicate that an individual's ability to "get the gist or extract the essence of a message" after a TBI more strongly predicts his or her ability to effectively hold a job or maintain a household than previously revealed by traditional cognitive tests alone.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
Species like dogs and rodents use their sense of smell to navigate toward desirable items and places and away from those they should avoid.
› Verified 5 days ago
Michael J Richards, D.P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 66 Park Street, Elizabethtown, NY 12932 Phone: 518-873-2408 | |
Dr. Sarah E Gardner, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 75 Park Street, Elizabethtown, NY 12932 Phone: 518-873-6377 Fax: 518-873-3097 | |
Mr. William Patrick Doherty, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 75 Park St, Elizabethtown, NY 12932 Phone: 518-873-2408 Fax: 518-873-3205 | |
Linda Mary Horizny, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 66 Park St, Elizabethtown, NY 12932 Phone: 518-873-2408 | |
Kevin Robert Bouchard-hall, PHYSICAL THERAPY Physical Therapist Medicare: Medicare Enrolled Practice Location: 66 Park Street, Suite 100, Elizabethtown, NY 12932 Phone: 518-873-2408 Fax: 518-873-3205 | |
Dawn Delmont Klotzko, MS, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 75 Park Street, Elizabethtown, NY 12932 Phone: 518-873-6377 Fax: 518-873-3097 | |
Daniel A Weber, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 66 Park St, Elizabethtown, NY 12932 Phone: 518-873-2408 Fax: 518-873-3205 |